title: Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria.
abstract: The etiology of chronic urticaria is largely unknown. The role of Helicobacter pylori infection, which is the most important cause of gastritis and peptic ulcer, is not clear in the pathophysiology of chronic urticaria. In this study, we aimed to define the impact of H. pylori on chronic urticaria. Thirty-eight patients who had chronic urticaria of unknown origin and dyspepsia were included in the study. In all patients, standard laboratory tests for detection of urticaria etiology were performed. Mean urticaria symptom scores of patients were carried out. All patients underwent upper gastrointestinal endoscopy. The presence of H. pylori was investigated using urease testing and histopathology. Duodenal fluid aspirated during upper endoscopy was examined for the presence of Giardia lamblia. H. pylori infection was detected in 29 patients. After successful eradication of H. pylori infection, the mean symptom score of patients did not change significantly (2.6 +/- 0.6 vs., 2.4 +/- 0.8). Only one patient had a total disappearance of urticaria symptoms. Out of 38 patients, only one had G. lamblia infection. The results of our study suggest that there is no association between H. pylori infection and chronic urticaria.
authors.affiliation: GATA, Allergy Department, Ankara, Turkey.
authors.forename: F
authors.initials: F
authors.lastname: Erel
authors.forename: O
authors.initials: O
authors.lastname: Sener
authors.forename: A
authors.initials: A
authors.lastname: Erdil
authors.forename: M
authors.initials: M
authors.lastname: Karaayvaz
authors.forename: G
authors.initials: G
authors.lastname: Gür
authors.forename: Z
authors.initials: Z
authors.lastname: Caliskaner
authors.forename: N
authors.initials: N
authors.lastname: Ozangüç
mesh_terms: D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002908:Chronic Disease; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005756:Gastritis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016829:Giardia lamblia / Q000276:immunology*; D005873:Giardiasis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009853:Omeprazole / Q000627:therapeutic use; D014581:Urticaria / Q000150:complications* / Q000276:immunology
chemical_list: D000897:Anti-Ulcer Agents; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole